William L. Macias - 05 Jan 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Medical Officer
Signature
/s/ Eva Renee Barnett, attorney-in-fact for William L. Macias
Issuer symbol
IMVT
Transactions as of
05 Jan 2022
Net transactions value
-$222,012
Form type
4
Filing time
07 Jan 2022, 11:39:01 UTC
Previous filing
09 Nov 2021
Next filing
20 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Sale $222,012 -26,813 -12% $8.28 197,340 05 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 11, 2021, the holder was granted 93,371 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021. These RSUs vested in their entirety on December 31, 2021. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs.